KURA

Kura Oncology, Inc. Common Stock

$15.75 +$0.20 +1.27%



Shares Bought5
Shares Sold5
Total10
Shares Owned0
Last Price$15.75
Total Return$6.05
Range Today$15.60 - $16.10
52 Week Range$4.72 - $16.75
Open$15.75
Market Cap$458.75M
Volume/Average75.93K/258.68K
P/E Ratio-
Dividend/Yield-




Kura Oncology, Inc. is a clinical-stage biopharmaceutical company engages in the research and development of medicines for the treatment of cancer. Its pipeline includes Tipifarnib which is a Farnesyl transferase inhibitor for HRAS Mutant Solid Tumors, Chronic Myelomonocytic Leukemia; KO-947 which is an ERK inhibitor for MAPK Pathway Tumors; and KO-539 which is a Menin MLL inhibitor for acute leukemias. The company was founded by Troy E. Wilson, Yi Liu, Pingda Ren and Antonio Gualberto on August 22, 2014 and is headquartered in La Jolla, CA.


Open Positions

Buy Date Buy Price Quote Return $ Return % Owners

Closed Positions

Buy Date Sell Date Buy Price Sell Price Return $ Return % Owners
09-13-17 15:01 09-14-17 15:19 $11.80 $12.00 +$0.20 +1.70% crizisaround
09-13-17 14:51 09-14-17 15:16 $11.95 $11.90 -$0.05 -0.40% crizisaround
09-08-17 13:46 09-08-17 17:13 $10.75 $12.85 +$2.10 +19.54% unholyurinal nekochan16
09-08-17 13:49 09-08-17 14:22 $10.90 $12.95 +$2.05 +18.81% crizisaround
09-08-17 13:48 09-08-17 14:21 $11.00 $12.75 +$1.75 +15.91% crizisaround numbtwitch unholyurinal nekochan16